MedTrace Logo

Instantaneous Wave-free Ratio Guidance Strategy Evaluation in the Treatment of Multivessel Acute Coronary Syndrome.

NCT05006183 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2022-04-29

No results posted yet for this study

Summary

A single-center, prospective, randomized, open-label, blinded end-point clinical trial of instantaneous wave-free ratio (iFR) guidance strategy impact on clinical outcomes in multivessel acute coronary syndrome (ACS) patients.

Conditions

  • Cardiac Ischemia
  • Acute Coronary Syndrome

Interventions

PROCEDURE

PCI

Percutaneous coronary intervention with Drug-Eluting Stents

Sponsors & Collaborators

  • Riga Stradins University

    collaborator OTHER

  • Daugavpils Regional Hospital

    lead OTHER_GOV

Principal Investigators

  • Deniss Vasiljevs, MD · Daugavpils Regional Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-08
Primary Completion
2023-08-31
Completion
2024-09-30

Countries

  • Latvia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05006183 on ClinicalTrials.gov